AP
Antipodes Partners Portfolio holdings
AUM
$3.22B
This Quarter Return
+12%
1 Year Return
+24%
3 Year Return
+103.24%
5 Year Return
+233.05%
10 Year Return
–
AUM
$3.22B
AUM Growth
+$3.22B
(+0.98%)
Cap. Flow
-$250M
Cap. Flow
% of AUM
-7.77%
Top 10 Holdings %
Top 10 Hldgs %
51.68%
Holding
123
New
21
Increased
40
Reduced
41
Closed
17
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$99.7M |
| 2 |
Workday
WDAY
|
$78M |
| 3 |
Westlake Corp
WLK
|
$62.5M |
| 4 |
Brinker International
EAT
|
$55.7M |
| 5 |
Nu Holdings
NU
|
$34.3M |
Top Sells
| 1 |
JD.com
JD
|
$121M |
| 2 |
KE Holdings
BEKE
|
$88.9M |
| 3 |
Alcoa
AA
|
$51.5M |
| 4 |
Cemex
CX
|
$49.8M |
| 5 |
B
Barrick Mining Corporation
B
|
$41.3M |
Sector Composition
| 1 | Technology | 21.12% |
| 2 | Healthcare | 17.28% |
| 3 | Financials | 14.4% |
| 4 | Materials | 12.43% |
| 5 | Consumer Discretionary | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Immunome
IMNM
$828M
| $95.4K | ﹤0.01% |
10,261
-3,903
| -28% | -$36.3K |
|
77
Establishment Labs
ESTA
$1.2B
| $87.5K | ﹤0.01% |
2,048
+73
| +4% | +$3.12K |
|
78
Certara
CERT
$1.74B
| $78K | ﹤0.01% |
6,665
+1,223
| +22% | +$14.3K |
|
79
DexCom
DXCM
$29.5B
| $73.7K | ﹤0.01% |
844
-1,118
| -57% | -$97.6K |
|
80
Steris
STE
$24.1B
| $62.5K | ﹤0.01% |
260
-273
| -51% | -$65.6K |
|
81
Cencora
COR
$56.5B
| $61.2K | ﹤0.01% |
+204
| New | +$61.2K |
|
82
Structure Therapeutics
GPCR
$1.11B
| $60.8K | ﹤0.01% |
2,932
-1,315
| -31% | -$27.3K |
|
83
GE Aerospace
GE
$292B
| $59.5K | ﹤0.01% |
231
+28
| +14% | +$7.21K |
|
84
Autodesk
ADSK
$67.3B
| $53.3K | ﹤0.01% |
172
+21
| +14% | +$6.5K |
|
85
Natera
NTRA
$23.1B
| $52.9K | ﹤0.01% |
313
+30
| +11% | +$5.07K |
|
86
Oric Pharmaceuticals
ORIC
$994M
| $52.7K | ﹤0.01% |
5,194
+1,372
| +36% | +$13.9K |
|
87
Lumen
LUMN
$5.1B
| $49.9K | ﹤0.01% |
11,386
| – | – |
|
88
908 Devices
MASS
$226M
| $46.8K | ﹤0.01% |
6,558
+2,176
| +50% | +$15.5K |
|
89
Henry Schein
HSIC
$8.44B
| $42.8K | ﹤0.01% |
+586
| New | +$42.8K |
|
90
Sagimet Biosciences
SGMT
$244M
| $41.2K | ﹤0.01% |
+5,412
| New | +$41.2K |
|
91
iRhythm Technologies
IRTC
$5.46B
| $39.3K | ﹤0.01% |
+255
| New | +$39.3K |
|
92
ARS Pharmaceuticals
SPRY
$1.15B
| $38.4K | ﹤0.01% |
2,201
-742
| -25% | -$12.9K |
|
93
Nuvalent
NUVL
$5.52B
| $36.6K | ﹤0.01% |
479
-61
| -11% | -$4.66K |
|
94
Ingersoll Rand
IR
$31.6B
| $26K | ﹤0.01% |
313
+38
| +14% | +$3.16K |
|
95
Apogee Therapeutics
APGE
$2.17B
| $25.9K | ﹤0.01% |
597
+55
| +10% | +$2.39K |
|
96
Schrodinger
SDGR
$1.44B
| $25.2K | ﹤0.01% |
1,252
-626
| -33% | -$12.6K |
|
97
Janux Therapeutics
JANX
$1.37B
| $24.2K | ﹤0.01% |
1,048
+416
| +66% | +$9.61K |
|
98
Core Scientific
CORZ
$4.38B
| $23.7K | ﹤0.01% |
+1,391
| New | +$23.7K |
|
99
NovoCure
NVCR
$1.38B
| $19.9K | ﹤0.01% |
+1,119
| New | +$19.9K |
|
100
Day One Biopharmaceuticals
DAWN
$769M
| $19.5K | ﹤0.01% |
3,006
+963
| +47% | +$6.26K |
|